Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

21
Number of overlapping holdings
16.5%
% of XBI's 128 holdings also in IDNA
50.0%
% of IDNA's 46 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XBI |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
CRISPR THERAPEUTICS AG | 1.9% | 4.6% | 1.9% | |
BLUEPRINT MEDICINES CORP. | 1.7% | 5.6% | 1.7% | |
BEAM THERAPEUTICS, INC. | 1.5% | 4.2% | 1.5% | |
EXELIXIS INC | 1.3% | 5.4% | 1.3% | |
REGENERON PHARMACEUTICALS | 1.3% | 5.2% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
MIRATI THERAPEUTICS INC | 2.1% | |
TG THERAPEUTICS INC | 1.6% | |
IONIS PHARMACEUTICALS, INC. | 1.6% | |
APELLIS PHARMACEUTICALS, INC. | 1.5% | |
IMMUNOVANT INC | 1.4% | |
SEATTLE GENETICS INC | 1.4% | |
HALOZYME THERAPEUTICS INC | 1.4% | |
BRIDGEBIO PHARMA, INC. | 1.4% | |
VERTEX PHARMACEUTICALS INC | 1.4% | |
IMMUNOGEN INC | 1.4% |
XBI Underweight Relative to IDNA
BIONTECH SE SPONSORED ADR | -4.4% | |
SANOFI-AVENTIS | -4.4% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% | |
EXELIXIS INC | -4.1% | |
GINKGO BIOWORKS HOLDINGS INC CLASS A | -4.1% | |
ROCHE HOLDING LTD | -4.0% | |
REGENERON PHARMACEUTICALS | -3.9% | |
BEIGENE, LTD. | -3.9% | |
GENMAB A/S | -3.9% | |
BLUEPRINT MEDICINES CORP. | -3.9% |